Safety of therapeutic immune globulin preparations with respect to transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection.
D000163:Acquired Immunodeficiency Syndrome / Q000635:transmission*; D000914:Antibodies, Viral / Q000032:analysis; D005591:Chemical Fractionation / Q000379:methods; D017977:Deltaretrovirus / Q000276:immunology; D004340:Drug Contamination; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage / Q000009:adverse effects*; D007275:Injections, Intravenous
D000914:Antibodies, Viral; D007136:Immunoglobulins; C045213:hepatitis B hyperimmune globulin